RLMD · NASDAQ · Biotechnology

Relmada Therapeutics (RLMD)

Develops NDV-01 for NMIBC and sepranolone for Prader-Willi syndrome.

$4.24
After hours−0.01 (−0.24%)
At close$4.25(+2.16%)